CIBC Bancorp USA’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
CIBC Bancorp USA's NVS Position: Q3 2026 in Review
CIBC Bancorp USA reduced its Novartis (NVS) stake by 2.7% in Q3 2026, selling an estimated $2.12M and leaving 510,112 shares worth $72.8M. The position accounts for 0.09% of the portfolio, ranked #196.
CIBC Bancorp USA first reported a position in NVS in Q1 2026 and has held it in 3 quarters since. The position peaked at $82.2M in Q1 2026. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- CIBC Bancorp USA held 510,112 shares of Novartis worth $72.8M as of Q3 2026.
- CIBC Bancorp USA sold 13,961 Novartis shares in Q3 2026, an estimated $2.12M.
- Novartis made up 0.09% of CIBC Bancorp USA's portfolio in Q3 2026, its #196 holding.
- CIBC Bancorp USA first reported a position in Novartis in Q1 2026 and has held it in 3 quarters since.
- CIBC Bancorp USA's Novartis position peaked at $82.2M in Q1 2026.
- 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.